Parkman Healthcare Partners’s uniQure QURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.38M Sell
206,842
-50,540
-20% -$1.02M 0.35% 72
2025
Q4
$6.16M Sell
257,382
-87,974
-25% -$3.39M 0.59% 53
2025
Q3
$20.2M Sell
345,356
-98,066
-22% -$1.78M 2.1% 14
2025
Q2
$6.18M Buy
443,422
+239,589
+118% +$3.22M 0.71% 53
2025
Q1
$2.16M Sell
203,833
-71,167
-26% -$998K 0.26% 73
2024
Q4
$4.86M Buy
+275,000
New +$2.37M 0.65% 45

Other funds holding QURE

Parkman Healthcare Partners's QURE Position: Q1 2026 in Review

Parkman Healthcare Partners reduced its uniQure (QURE) stake by 20% in Q1 2026, selling an estimated $1.02M and leaving 206,842 shares worth $3.38M. The position accounts for 0.35% of the portfolio, ranked #72.

Parkman Healthcare Partners first reported a position in QURE in Q4 2024 and has held it in 6 quarters since. The position peaked at $20.2M in Q3 2025. 212 funds tracked by Wall St. Rank hold QURE as of Q1 2026.

  • Parkman Healthcare Partners held 206,842 shares of uniQure worth $3.38M as of Q1 2026.
  • Parkman Healthcare Partners sold 50,540 uniQure shares in Q1 2026, an estimated $1.02M.
  • uniQure made up 0.35% of Parkman Healthcare Partners's portfolio in Q1 2026, its #72 holding.
  • Parkman Healthcare Partners first reported a position in uniQure in Q4 2024 and has held it in 6 quarters since.
  • Parkman Healthcare Partners's uniQure position peaked at $20.2M in Q3 2025.
  • 212 funds tracked by Wall St. Rank held uniQure as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.